Researchers all over the world are fighting tooth and nail to identify chinks in the armor of the new coronavirus mutation, called the Omicron variant, which has spread fear throughout the population and the markets over the past few days.
Moderna, Pfizer/Biontech, Johnson & Johnson and Astrazeneca, which have all developed first-generation Covid-19 vaccines, have all started sequencing the new variant, reports the Financial Times.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.